Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietinalpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy - UPDATE 2003;Recommandations pour la pratique clinique: Standards, Options et Recommandations 2003 pour l'utilisation de l'érythropoïétine recombinante (époetine alfa et bêta, darbepoetine alfa, EPO) dans la prise en charge de l'anémie en cancérologie pour les patients traités par radiothérapie, mise à jour

Cancer/Radiotherapie

Volumn 8, Issue 3, 2004, Pages 197-206

[No Author Info available]

Author keywords

Anaemia; Cancer; Clinical practice guideline; Neoplasms; Radiotherapy; Recombinant erythropoeitin; rHuEPO

Indexed keywords

HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER CELL; CANCER RADIOTHERAPY; CLINICAL TRIAL; EMBASE; HUMAN; HYPOPHARYNX TUMOR; MEDICAL SOCIETY; MEDLINE; METHODOLOGY; MOUTH TUMOR; ONCOLOGY; OROPHARYNX TUMOR; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL RATE; TIME SERIES ANALYSIS;

ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FRANCE; HEMOGLOBINS; HUMANS; INTERINSTITUTIONAL RELATIONS; NEOPLASMS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; RADIOTHERAPY;

EID: 3042674226     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2004.04.001     Document Type: Article

References (11)

1. Dusenbery KE, McGuire WA, Holt PJ, Carson LF, Fowler JM, Twiggs LB, et al. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. International Journal of Radiation Oncology, Biology, Physics 1994;29:1079-84.
2. Fervers B, Bonichon F, Demard F, Heron JF, Mathoulin S, Philip T. Méthodologie de développement des Standards, Options et Recommandations diagnostiques et thérapeutiques en cancérologie. Bull Cancer 1995;82:761-7.
3. Fervers B, Hardy J, Blanc-Vincent MP, Theobald S, Bataillard A, Farsi F, et al. SOR: project methodology. Br J Cancer 2001;84:8-16.
4. Glaser CM, Millesi W, Kornek GV, Lang S, Spacing D, Watzinger F, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. International Journal of Radiation Oncology, Biology, Physics 2001;50:705-15.
5. Henke M, Guttenberger R, Barke A, Pajonk F, Potter R, Frommhold H. Erythropoietin for patients undergoing radiotherapy: a pilot study. Radiother Oncol 1999;50:185-90.
6. Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebocontrolled trial. Lancet 2003;362:1255-60.
7. Lavey RS, Dempsey WH. Erythropoietin increases hemoglobin in cancer patients during radiation therapy. International Journal of Radiation Oncology, Biology, Physics 1993;27:1147-52.
8. Spaeth D, Casadevall N, Daouphars M, Marchal C, Marec-Berard P, Fabre N, et al. Recommandations pour la pratique clinique: Standards, Options et Recommandations 2003 pour l'utilisation de l'érythropoïétine recombinante (eacute;poetine alfa et bêta, darbepoetine alfa, EPO) dans la prise en charge de l'aneacute;mie en canceacute;rologie, mise à jour (rapport inteacute;gral) [online]. 2003/11. Available: URL: http://www.fnclcc. com/fr/sor/pdf/TT_MED_Util_EPO_int.pdf.
9. Spaeth D, Marchal C, Blanc-Vincent MP. Elements de la mise à jour 1999 des Standards, Options et Recommandations pour l'utilisation de l'erythropoietine en cancerologie. Bull Cancer 1999;86:631-9.
10. Spaeth D, Marchal C, Blanc-Vincent MP. Standards, Options et Recommandations pour l'utilisation de l'erythropoietine en cancerologie. Bull Cancer 1998;85:337-46.
11. Sweeney PJ, Nicolae D, Ignacio L, Chen L, Roach M, III,Wara W, et al. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, openlabelled, phase II trial. British Journal of Cancer 1998;77:1996-2002.